Neurology clinical trials recruiting in California

218 recruiting neurology trials match in California. Showing 20.

• A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor FluctuationsRecruiting

  Phase 2 · Appello Pharmaceuticals, Inc. · Carlsbad, California

• Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease DementiaRecruiting

  Phase 2 / Phase 3 · Exciva GmbH · Murrieta, California

• Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy PatientsRecruiting

  N/A · Baylor College of Medicine · Los Angeles, California

• Randomized Study in Children and Adolescents With Migraine: Acute TreatmentRecruiting

  Phase 3 · Pfizer · Anaheim, California

• TREAD: Time Restricted Eating Intervention for Alzheimer's DiseaseRecruiting

  Phase 1 · University of California, San Diego · San Diego, California

• Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)Recruiting

  Phase 1 / Phase 2 · University of California, Los Angeles · Los Angeles, California

• DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial CancerRecruiting

  Phase 3 · AstraZeneca · Duarte, California

• A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)Recruiting

  Phase 3 · Merck Sharp & Dohme LLC · Burbank, California

• A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease PsychosisRecruiting

  Phase 2 · MapLight Therapeutics · Anaheim, California

• Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)Recruiting

  Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · Anaheim, California

• Biomarker Exploration in Aging, Cognition and NeurodegenerationRecruiting

  Phase 3 · University of California, Irvine · Irvine, California

• Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial PainRecruiting

  Phase 2 · Stanford University · Stanford, California

• A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)Recruiting

  Phase 1 · Eli Lilly and Company · Los Alamitos, California

• A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet SyndromeRecruiting

  Phase 3 · Epygenix · Orange, California

• ECoG BMI for Motor and Speech ControlRecruiting

  N/A · Karunesh Ganguly · San Francisco, California

• Caring Recharge Project for Caregivers of Individuals With Alzheimer's DiseaseRecruiting

  Phase 2 · Photozig, Inc. · Campbell, California

• Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))Recruiting

  Phase 3 · Neurona Therapeutics · Los Angeles, California

• Alzheimer Prevention Trials (APT) WebstudyRecruiting

  N/A · University of Southern California · San Diego, California

• A Study of Psychedelics in Healthy Older Adults With Low Well-beingRecruiting

  Phase 1 · Jennifer Mitchell · San Francisco, California

• A Study of Orelabrutinib in Patients With Secondary Progressive Multiple SclerosisRecruiting

  Phase 3 · Zenas BioPharma (USA), LLC · Fullerton, California

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.